[144] Dorman Products, Inc. New SEC Filing

Rhea-AI Filing Summary

Dorman Products, Inc. (DORM) filed a Form 144 reporting a proposed sale of 2,231 common shares with an aggregate market value of $317,597.63. The filing lists 30,534,243 shares outstanding and an approximate sale date of 08/11/2025 on NASDAQ.

The securities were acquired by the filer through stock option exercises (618 shares on 04/26/2018; 859 shares on 03/03/2023) and restricted stock vesting (754 shares on 03/01/2024), with payment described as cash for the exercises and compensation for the vesting. The filing notes Nothing to Report for sales during the past three months and includes the standard attestation that the filer does not know of undisclosed material adverse information. Submission is marked LIVE.

Insights

Financial Analyst

TL;DR: Routine Rule 144 notice showing a proposed sale of 2,231 shares valued at $317,597.63.

The filing documents a proposed sale of 2,231 common shares with an aggregate market value of $317,597.63 and an approximate sale date of 08/11/2025 on NASDAQ. Acquisition details are provided for each lot: stock option exercises on 04/26/2018 (618 shares) and 03/03/2023 (859 shares), and restricted stock vesting on 03/01/2024 (754 shares). The filer reports no sales in the past three months and signs the usual representation regarding material nonpublic information. On its face, this is a procedural disclosure required for intended insider sales.

Corporate Governance Expert

TL;DR: Disclosure appears complete for a Rule 144 sale; no recent sales reported and standard attestation included.

The Form 144 contains the necessary elements for a proposed insider sale: the class of security, broker details, the number of shares to be sold (2,231), aggregate market value ($317,597.63), outstanding shares reported (30,534,243), and the listed sale date (08/11/2025). Acquisition history and payment types are stated for the specific lots. The filing is marked LIVE and contains the signer’s representation about undisclosed material information, consistent with regulatory expectations for such notices.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2231	317597.63	30534243	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/26/2018	Stock Option Exercise	Issuer			618	04/26/2018	Cash
Common	03/03/2023	Stock Option Exercise	Issuer			859	03/03/2023	Cash
Common	03/01/2024	Restricted Stock Vesting	Issuer			754	03/01/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Dorman Products (DORM) Form 144 report?

The filing reports a proposed sale of 2,231 common shares with an aggregate market value of $317,597.63 and an approximate sale date of 08/11/2025 on NASDAQ.

How were the 2,231 shares acquired according to the filing?

Acquisition details: 618 shares from a stock option exercise on 04/26/2018 (cash); 859 shares from a stock option exercise on 03/03/2023 (cash); 754 shares from restricted stock vesting on 03/01/2024 (compensation).

Did the filer report any securities sold in the past three months for DORM?

No. The filing lists "Nothing to Report" for securities sold during the past three months.

How many shares outstanding does the Form 144 state for the issuer?

The filing lists 30,534,243 shares outstanding.

Does the filer make any attestation about material information?

Yes. The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.